Device / Technology News

RSS

FUJIFILM introduces Synapse Cardiovascular 4.0.8

Today at the 61st annual American College of Cardiology (ACC) Summit in Chicago, Ill., FUJIFILM Medical Systems U.S.A., Inc. introduced Synapse Cardiovascular 4.0.8, the latest version of their web based solution for cardiovascular imaging.

26 Mar 2012

New method for measurement of aggregated beta-amyloid in AD

An international team of researchers have developed a new method for measurement of aggregated beta-amyloid - a protein complex believed to cause major nerve cell damage and dysfunction in Alzheimer's disease. The new method might facilitate diagnosis and detection as well as development of drugs directed against aggregated beta-amyloid.

26 Mar 2012

TPPF introduces PPACAction.com website

The Texas Public Policy Foundation announces the launch of PPACAction.com, a special website devoted to live coverage of next week's U.S. Supreme Court argument in Florida v. HHS. The case, to be taken up by the Court March 26 through 28, involves the constitutionality of the Patient Protection and Affordable Care Act (PPACA) signed into law by President Barack Obama in March 2010.

26 Mar 2012

Toshiba to showcase Infinix-i vascular X-ray product line at SIR annual meeting

Committed to developing technology to make vascular procedures faster, easier and safer, Toshiba America Medical Systems, Inc. introduces new software for its Infinix-i vascular X-ray systems, enabling high-speed 3D reconstruction and low-contrast imaging.

26 Mar 2012

Medgenics to commence EPODURE Biopumps Phase IIa study in ESRD-related anemia

Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced receipt of clearance from the Israeli Ministry of Health to initiate a Phase IIa clinical study evaluating the safety and efficacy of sustained erythropoietin therapy produced and delivered by the Company's EPODURE Biopumps.

26 Mar 2012

FDA Advisory Committee to review Repligen's SecreFlo NDA on May 31

Repligen Corporation today announced that the U.S. Food and Drug Administration's Gastrointestinal Drugs Advisory Committee will meet on May 31, 2012 to discuss the Company's New Drug Application (NDA) for SecreFlo for the improved detection of pancreatic duct abnormalities in combination with magnetic resonance imaging (MRI) in patients with pancreatitis.

26 Mar 2012

Real-time, non-invasive test to detect heart attack

What if your doctor could tell you in real-time, with a non-invasive test as to whether or not you might be having an acute myocardial infarction (AMI) or in simpler terms, a heart attack?

23 Mar 2012

Canon to showcase RK-F2 Full Auto Ref-Keratometer at Vision Expo East

Canon U.S.A., Inc., a leader in digital imaging solutions, will demonstrate the benefits of using its digital imaging and workflow management solutions, including the Canon RK-F2 Full Auto Ref-Keratometer, during Vision Expo East, March 23 - 25, at the Jacob K. Javits Convention Center in New York.

23 Mar 2012

New information service on Medicare and Medicaid EHR incentive programs

Proxy Capital today announced the launch of a new, free information service, MaxEHR.com. The MaxEHR.com website provides doctors and other medical professionals with the information they need to maximize their incentives and productivity from adopting and using electronic health records (EHR).

23 Mar 2012

Fraunhofer FIT software rapidly analyzes complex biological processes

At Analytica 2012, Fraunhofer FIT presents software that supports the search for new active pharmaceutical ingredients of cancer drugs. Through a high degree of parallelization, the software can analyze complex biological processes very fast, even with large amounts of data.

23 Mar 2012

FDA clears multiple enhancements to St. Jude Medical's FFR measurement guidewire

St. Jude Medical, Inc., a global medical device company, today announced it has received U.S. Food and Drug Administration (FDA) clearance for multiple enhancements to its PressureWire Fractional Flow Reserve (FFR) measurement guidewire.

23 Mar 2012

Mendelian randomization not the 'Holy Grail' in evaluating alcohol intake with cognitive function

Many observational cohort studies have shown that moderate alcohol use is associated with better cognitive function. However, since such studies are vulnerable to residual confounding by other lifestyle and physiologic factors, the authors conducted a Mendelian randomization study, using aldehyde dehydrogenase 2 (ALDH2) genotype (AA, GA, or GG) as an instrumental variable in 2-stage least squares analysis.

23 Mar 2012

Relief for dry eyes through scleral contact lenses

Susan Loughman is among the tens of millions of Americans who suffer dry eyes. She has an especially bad condition, which makes it feel like there's sandpaper in her eyes.

23 Mar 2012

Ultrasound-guided surgery more successful in removing breast tumours

The use of ultrasound-guided surgery to remove tumours from women who have palpable breast cancer is much more successful than standard surgery in excising all the cancerous tissue while sparing as much healthy tissue as possible, according to the results of a randomised controlled trial.

23 Mar 2012

$Bronchoscopy helps distinguish phenotypes, personalize therapy for refractory asthma$

Bronchoscopy helps distinguish phenotypes, personalize therapy for refractory asthma

Using a bronchoscope to visually examine the airways and collect fluid and tissue can help guide effective therapy for difficult-to-treat asthma patients, according to researchers at National Jewish Health.

23 Mar 2012

Uppsala University researchers identify promising biomarkers for ASD

An important step towards developing a rapid, inexpensive diagnostic method for autism has been take by Uppsala University, among other universities. Through advanced mass spectrometry the researchers managed to capture promising biomarkers from a tiny blood sample.

23 Mar 2012

Quest Diagnostics unveils redesigned corporate website

Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, has unveiled its redesigned corporate website at www.QuestDiagnostics.com.

From Quest Diagnostics 23 Mar 2012

OncoSec to present data from head and neck cancer studies at two upcoming conferences

OncoSec Medical Incorporated., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that the company has been selected to present data from its Phase III and IV head and neck cancer studies at two upcoming conferences.

23 Mar 2012

IBM, MSKCC partner to develop decision support tool for oncologists

Memorial Sloan-Kettering Cancer Center (MSKCC) and IBM have agreed to collaborate on the development of a powerful tool built upon IBM Watson in order to provide medical professionals with improved access to current and comprehensive cancer data and practices.

23 Mar 2012